7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Dyslipidemia
Dyslipidemia is a medical condition marked by an abnormal lipid profile, encompassing cholesterol and triglycerides in the bloodstream. Its significance lies in its association with the development of cardiovascular diseases, notably atherosclerosis and coronary artery disease. This condition arises from disruptions in lipid production, utilization, or clearance, resulting in elevated levels of LDL cholesterol, often termed "bad" cholesterol, and decreased levels of HDL cholesterol, referred to as "good" cholesterol. Contributing factors to dyslipidemia include a combination of genetic predisposition, lifestyle choices, and underlying health conditions. Unhealthy dietary patterns, sedentary lifestyle, and obesity play substantial roles in its onset.
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United StatesSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt